一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> ACS Applied Materials & Interfaces >>article
ACS Applied Materials & Interfaces

ACS Applied Materials & Interfaces

IF: 8.3
Download PDF

CpG-Conjugated Silver Nanoparticles as a Multifunctional Nanomedicine to Promote Macrophage Efferocytosis and Repolarization for Atherosclerosis Therapy

Published:1 November 2023 DOI: 10.1021/acsami.3c11227 PMID: 37910772
Cui Tang, Hui Wang, Lina Guo, Chan Zou, Jianming Hu, Hanyong Zhang, Wenhu Zhou* and Guoping Yang*, 

Abstract

Atherosclerosis (AS) is a major contributor to cardiovascular diseases, necessitating the development of novel therapeutic strategies to alleviate plaque burden. Macrophage efferocytosis, the process by which macrophages clear apoptotic and foam cells, plays a crucial role in plaque regression. However, this process is impaired in AS lesions due to the overexpression of CD47, which produces a “do not eat me” signal. In this study, we investigated the potential of CpG, a toll-like receptor 9 agonist, to enhance macrophage efferocytosis for AS therapy. We demonstrated that CpG treatment promoted the engulfment of CD47-positive apoptotic cells and foam cells by macrophages. Mechanistically, CpG induced a metabolic shift in macrophages characterized by enhanced fatty acid oxidation and de novo lipid biosynthesis, contributing to its pro-efferocytic effect. To enable in vivo application, we conjugated CpG on silver nanoparticles (AgNPs) to form CpG-AgNPs, which could protect CpG from biological degradation, promote its cellular uptake, and release CpG in response to intracellular glutathione. Combining the intrinsic antioxidative and anti-inflammatory abilities of AgNPs, such nanomedicine displayed multifunctionalities to simultaneously promote macrophage efferocytosis and repolarization. In an ApoE–/– mouse model, intravenous administration of CpG-AgNPs effectively targeted atherosclerotic plaques and exhibited potent therapeutic efficacy with excellent biocompatibility. Our study provides valuable insights into CpG-induced macrophage efferocytosis and highlights the potential of CpG-AgNPs as a promising therapeutic strategy for AS.

Substances (2)

Materials
Procduct Name CAS Molecular Formula Supplier Price
BMS 303141 943962-47-8 C19H15Cl2NO4S 146 suppliers $15.00-$2691.10
BMS 303141 943962-47-8 C19H15Cl2NO4S 146 suppliers $15.00-$2691.10

Similar articles

IF:5.3

Preparation and characterization of Tamoxifen citrate loaded nanoparticles for breast cancer therapy.

ACS Applied Nano Materials Ruma Maji, Niladri Shekhar Dey,etc Published: 25 June 2014
IF:10

Hybrid Cell Membrane‐Coated Nanoparticles for Synergizing Sonodynamic Therapy and Immunotherapy against Triple‐Negative Breast Cancer

Advanced Healthcare Materials Jiali Gong, Danling Cheng,etc Published: 21 November 2024
IF:2.1

Salidroside - Can it be a Multifunctional Drug?

Current drug metabolism Sri Krishna Jayadev Magani, Sri Durgambica Mupparthi,etc Published: 1 January 2020
阿鲁科尔沁旗| 大姚县| 五大连池市| 车致| 吕梁市| 平利县| 汪清县| 呼图壁县| 商城县| 师宗县| 张家川| 卢氏县| 汉源县| 红原县| 兴文县| 赤水市| 湖南省| 益阳市| 崇仁县| 太湖县| 崇礼县| 台北市| 牟定县| 巢湖市| 河西区| 仁寿县| 祁阳县| 祁门县| 和静县| 定远县| 施甸县| 林甸县| 三门县| 太白县| 承德县| 青河县| 宁远县| 改则县| 清原| 绥宁县| 紫阳县|